Schroder Investment Management Group’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.7M	Buy	246,916 +54,544	+28%	+$1.26M	﹤0.01%	744
2025 Q1	$5.6M	Buy	192,372 +35,498	+23%	+$1.03M	0.01%	742
2024 Q4	$8.24M	Buy	156,874 +82,601	+111%	+$4.34M	0.01%	684
2024 Q3	$3.44M	Buy	74,273 +39,092	+111%	+$1.81M	﹤0.01%	861
2024 Q2	$1.47M	Buy	+35,181	New	+$1.47M	﹤0.01%	973